FDA takes steps to enhance state importation programs to help lower prescription drug prices
FDA takes steps to enhance state importation programs to help lower prescription drug prices
http://www.fda.gov/news-events/press-announcements/fda-takes-steps-enhance-state-importation-programs-help-lower-prescription-drug-prices
FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease
FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease
http://www.fda.gov/news-events/press-announcements/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease
FDA to Host Inaugural, Independent, Scientific Expert Panel Open to Public
FDA to Host Inaugural, Independent, Scientific Expert Panel Open to Public
http://www.fda.gov/news-events/press-announcements/fda-host-inaugural-independent-scientific-expert-panel-open-public
FDA Advances Robust, Transparent Post-Market Chemical Review Program to Keep Food Supply Safe and Healthy
FDA Advances Robust, Transparent Post-Market Chemical Review Program to Keep Food Supply Safe and Healthy
http://www.fda.gov/news-events/press-announcements/fda-advances-robust-transparent-post-market-chemical-review-program-keep-food-supply-safe-and
FDA Begins Action To Remove Ingestible Fluoride Prescription Drug Products for Children from the Market
FDA Begins Action To Remove Ingestible Fluoride Prescription Drug Products for Children from the Market
http://www.fda.gov/news-events/press-announcements/fda-begins-action-remove-ingestible-fluoride-prescription-drug-products-children-market
HHS, FDA Initiate Comprehensive Review of Nutrients in Infant Formula
HHS, FDA Initiate Comprehensive Review of Nutrients in Infant Formula
http://www.fda.gov/news-events/press-announcements/hhs-fda-initiate-comprehensive-review-nutrients-infant-formula
HHS, FDA Issue RFI on Deregulatory Plan to Lower Costs and Empower Providers
HHS, FDA Issue RFI on Deregulatory Plan to Lower Costs and Empower Providers
http://www.fda.gov/news-events/press-announcements/hhs-fda-issue-rfi-deregulatory-plan-lower-costs-and-empower-providers
FDA and CDC Recommend Pause in Use of Ixchiq (Chikungunya Vaccine, Live) in Individuals 60 Years of Age and Older While Postmarketing Safety Reports are Investigated: FDA Safety Communication
FDA and NIH Announce Innovative Joint Nutrition Regulatory Science Program
FDA and NIH Announce Innovative Joint Nutrition Regulatory Science Program
http://www.fda.gov/news-events/press-announcements/fda-and-nih-announce-innovative-joint-nutrition-regulatory-science-program